Oncology
IntelliView 360™
IntelliView 360™….the only Oncology Omnibus with a validated panel bridging the gap between Primary and Secondary Research. A first time offering in the U.S. Oncology Market.
Use IntelliView 360™
» When time is a constraint — suits small or large qualitative studies
» When you need to solve budget limitations — ad-hoc research at multi-client cost-effective pricing
» To obtain answers quickly — on a conveniently scheduled basis
» To access a validated panel of respondents — bridging primary and secondary research resources
The IntelliView 360 Oncology Omnibus
IntelliView 360™ links IntrinsiQ oncologist practice information with primary research to bridge the gap between actual patient treatment and reported activities. IntelliView 360 ties attitudes, opinions, and views to IntrinsiQ data through a validated panel of medical and hematology oncologists – the same oncologists that use the IntrinsiQ IntelliDose® computerized order entry system to capture actual treatment records. Designed to deliver fast, reliable, and cost effective results, IntelliView 360 is an omnibus research offering that combines custom-designed, telephone interview questions with IntrinsiQ secondary research data. Field research dates are conveniently scheduled around major conferences such as ASCO, ESMO, and ASH.
Click here for a calendar
The IntrinsiQ Panel
IntelliView 360™ provides unparalleled access to IntelliDose oncologists. Panel members manage the treatment of over 19,500 unique patients per month and practice in settings ranging from academic medical centers to hospitals to multi-specialty private practices. IntelliView 360 panel oncologists focus on breast, lung, colorectal, and lymphoma treatment. IntrinsiQ’s strong relationships with IntelliDose oncologists ensure dependable insights and quality data as well as consistency from a constant panel of participating practices.
The Team
IntrinsiQ - The Gold Standard in Oncology
» The only validated information source for projected, regular, and complete oncology practice behavior
» The largest provider of oncology information to pharmacology and biotechnology industries
» The source of monthly data on over 135,000 drug administrations to over 19,500 patients
WWMR - Primary Research Expertise
» Fifteen years of market research experience with over ten years in oncology
» In-person/telephone interview, Internet survey, and focus group expertise
» Oncology and oncology supportive care therapy experience
The Results
IntelliView 360 results are delivered quickly - within three to four weeks from approval of the final questionnaire. Results are delivered in a PowerPoint presentation of research findings with executive analysis. Reports include both the perceptions of panel oncologists and perspectives on their treatment practices.
This new EP Publication provides an epidemiological forecast for key
types of conditions associated with cancer pain in the US market in
2008, 2013 and 2018.
This report presents expert analysis of the commercial potential and
key differences among products in development for the treatment of
cancer pain and describes the critical factors driving cancer pain
market grown through 2018.
This report includes an exclusive 30 page PowerPoint Presentation of
the findings from Clinician Interviews and survey of 100 Pain
Clinician Interviews. The summary of our qualitative in-depth
discussions and quantitative survey provides quotes, and is a
tremendously cost-effective supplement to any Marketing Research
budget.
PANCREATIC CANCER MARKET INTELLIGENCE PROGRAM
A New Venture from Intrinsiq Research and WWMR,
Inc., Based On:
- Analysis of real-time chemotherapy orders
- Longitudinal portrait of patient population
- Assessment of investigational treatments
|